Prevest Denpro Ltd
₹0.00▲ +0.00 (+0.00%)
PREVESTLTD·NSE·Healthcare
Market Cap
468.92 Cr
PE Ratio
21.60
Volume
—
Day High - Low
—
52W High-Low
605.00 - 318.15
₹0.00▲ +0.00 (+0.00%)
Market Cap468.92 Cr
PE Ratio21.60
Volume—
Day High - Low—
52W High-Low605.00 - 318.15
Prevest Denpro Ltd (PREVESTLTD): company summary
Prevest Denpro Ltd (PREVESTLTD) is a micro-cap Healthcare company valued at ₹469 crore operating in Medical Equipment on the NSE and BSE.
Prevest Denpro Ltd (PREVESTLTD) is a micro-cap Healthcare company valued at ₹469 crore operating in Medical Equipment on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 15.3% a year over three years; profit grew 8.6% a year, behind revenue — margins are under pressure. Return on equity is 18.5%.
- Valuation multiples
- The stock trades at 21.6 times earnings, a discount to the Healthcare median of 32.0, 3.76 times book value. It yields 0.3%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
6.8/10
Fair
Fair Value
Sign in to see
ROE
18.50%
Strong
P/E
21.60x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Medical Equipment
Overall View
Fair
Price performance
52W₹318.15
₹605.00
DocStoX take
Supported by growth (8.3) and quality (8.2), but held back by valuation (3.5). Scored on 4 of 5 measures.
DocStoX score
Medium confidence6.8
/10
Fair
Quality
Excellent
ROE 18.5%
Valuation
Rich
P/E 21.6×
Growth
Strong
Revenue +22.3% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹469 Cr
52W High / Low
₹605 / ₹318
Dividend Yield
0.26%
Promoter Holding
73.60%
EPS (TTM)
₹15.16
Book Value
₹103.97
Key highlights
- Low leverage — D/E 0.00
- Healthy net margin (29%)
- Profitable in all of the last 5 years
- Small ₹469 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment
Explore Prevest Denpro Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Prevest Denpro Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Prevest Denpro Ltd with peers
Prevest Denpro Ltd vs Sun Pharmaceutical Industries LimitedPrevest Denpro Ltd vs Divi's Laboratories LimitedPrevest Denpro Ltd vs Torrent Pharmaceuticals LimitedPrevest Denpro Ltd vs Apollo Hospitals Enterprise LimitedPrevest Denpro Ltd vs Zydus Lifesciences LimitedPrevest Denpro Ltd vs Laurus Labs Limited
Related tools & concepts
Value Prevest Denpro Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing